The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Procainamide Is a Specific Inhibitor of DNA Methyltransferase 1
Open accessAbstract
CpG island hypermethylation occurs in most cases of cancer, typically resulting in the transcriptional silencing of critical cancer genes. Procainamide has been shown to inhibit DNA methyltransferase activity and reactivate silenced gene expression in cancer cells by reversing CpG island hypermethylation. We report here that procainamide specifically inhibits the hemimethylase activity of DNA methyltransferase 1 (DNMT1), the mammalian enzyme thought to be responsible for maintaining DNA methylation patterns during replication. At micromolar concentrations, procainamide was found to be a partial competitive inhibitor of DNMT1, reducing the affinity of the enzyme for its two substrates, hemimethylated DNA and S-adenosyl-l-methionine. By doing so, procainamide significantly decreased the processivity of DNMT1 on hemimethylated DNA. Procainamide was not a potent inhibitor of the de novo methyltransferases DNMT3a and DNMT3b2. As further evidence of the specificity of procainamide for DNMT1, procainamide failed to lower genomic 5-methyl-2'-deoxycytidine levels in HCT116 colorectal cancer cells when DNMT1 was genetically deleted but significantly reduced genomic 5-methyl-2'-deoxycytidine content in parental HCT116 cells and in HCT116 cells where DNMT3b was genetically deleted. Because many reports have strongly linked DNMT1 with epigenetic alterations in carcinogenesis, procainamide may be a useful drug in the prevention of cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The fundamental role of epigenetic events in cancer
Jones, P. A., & Baylin, S. B. (2002) · Nature Reviews Genetics · doi:10.1038/nrg816 · Cited by 5,648
Enzyme kinetics; behavior and analysis of rapid equilibrium and steady state enzyme systems
(1994) · International Journal of Biochemistry · doi:10.1016/0020-711x(94)90021-3 · Cited by 2,972
Cellular differentiation, cytidine analogs and DNA methylation
Jones, P. A., & Taylor, S. M. (1980) · Cell · doi:10.1016/0092-8674(80)90237-8 · Cited by 1,831
Christman, J. K. (2002) · Oncogene · doi:10.1038/sj.onc.1205699 · Cited by 1,525
Induction of tumors in mice by genomic hypomethylation
Gaudet, F., Hodgson, J. G., Eden, A., Jackson-Grusby, L., Dausman, J., Gray, J. W., Leonhardt, H., & Jaenisch, R. (2003) · Science · doi:10.1126/science.1083558 · Cited by 1,499
A targeting sequence directs DNA methyltransferase to sites of DNA replication in mammalian nuclei
Leonhardt, H., Page, A. W., Weier, H.-U., & Bestor, T. H. (1992) · Cell · doi:10.1016/0092-8674(92)90561-p · Cited by 1,055
DNMT1 and DNMT3b cooperate to silence genes in human cancer cells
Rhee, I., Bachman, K. E., Park, B. H., Jair, K.-W., Yen, R.-W. C., Schuebel, K. E., Cui, H., Feinberg, A. P., Lengauer, C., Kinzler, K. W., et al. (2002) · Nature · doi:10.1038/416552a · Cited by 1,039
Number of CpG islands and genes in human and mouse.
Antequera, F., & Bird, A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11995 · Cited by 996
Human DNA-(Cytosine-5) Methyltransferase-PCNA Complex as a Target for p21 WAF1
Chuang, L. S.-H., Ian, H.-I., Koh, T.-W., Ng, H.-H., Xu, G., & Li, B. F. L. (1997) · Science · doi:10.1126/science.277.5334.1996 · Cited by 902
Suppression of intestinal neoplasia by DNA hypomethylation
Laird, P. W., Jackson-Grusby, L., Fazeli, A., Dickinson, S. L., Edward Jung, W., Li, E., Weinberg, R. A., & Jaenisch, R. (1995) · Cell · doi:10.1016/0092-8674(95)90329-1 · Cited by 710
Recombinant Human DNA (Cytosine-5) Methyltransferase
Pradhan, S., Bacolla, A., Wells, R. D., & Roberts, R. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.46.33002 · Cited by 651
DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells
Robert, M.-F., Morin, S., Beaulieu, N., Gauthier, F., Chute, I. C., Barsalou, A., & MacLeod, A. R. (2003) · Nature Genetics · doi:10.1038/ng1068 · Cited by 614
Hermann, A., Goyal, R., & Jeltsch, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403427200 · Cited by 569
Inhibition of DNA Methylation and Reactivation of Silenced Genes by Zebularine
Cheng, J. C., Matsen, C. B., Gonzales, F. A., Ye, W., Greer, S., Marquez, V. E., Jones, P. A., & Selker, E. U. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.5.399 · Cited by 535
CpG methylation is maintained in human cancer cells lacking DNMT1
Rhee, I., Jair, K.-W., Yen, R.-W. C., Lengauer, C., Herman, J. G., Kinzler, K. W., Vogelstein, B., Baylin, S. B., & Schuebel, K. E. (2000) · Nature · doi:10.1038/35010000 · Cited by 453
Approval Summary: Azacitidine for Treatment of Myelodysplastic Syndrome Subtypes
Kaminskas, E., Farrell, A., Abraham, S., Baird, A., Hsieh, L.-S., Lee, S.-L., Leighton, J. K., Patel, H., Rahman, A., Sridhara, R., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2135 · Cited by 423
Hydralazine and procainamide inhibit T cell DNA methylation and induce autoreactivity.
Cornacchia, E., Golbus, J., Maybaum, J., Strahler, J., Hanash, S., & Richardson, B. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.140.7.2197 · Cited by 420
Changes in DNA Methylation in Neoplasia: Pathophysiology and Therapeutic Implications
Santini, V., Kantarjian, H. M., & Issa, J.-P. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-7-200104030-00011 · Cited by 414
Procaine is a DNA-demethylating agent with growth-inhibitory effects in human cancer cells.
Villar‐Garea, A., Fraga, M. F., Espada, J., & Esteller, M. (2003) · PubMed · Cited by 316
Inhibition of DNA methylation and histone deacetylation prevents murine lung cancer.
Belinsky, S. A., Klinge, D. M., Stidley, C. A., Issa, J. J., Herman, J. G., March, T. H., & Baylin, S. B. (2003) · PubMed · Cited by 293
Vertino, P. M., Yen, R.-W. C., Gao, J., & Baylin, S. B. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.8.4555 · Cited by 288
5-Azacytidine, a new, highly effective cancerostatic
Šorm, F., Pískala, A., Čihák, A., & Veselý, J. (1964) · Experientia · doi:10.1007/bf02135399 · Cited by 286
CG island methylation changes near the GSTP1 gene in prostatic intraepithelial neoplasia.
Brooks, J. D., Weinstein, M. H., Lin, X., Sun, Y., Pin, S. S., Bova, G. S., Epstein, J. I., Isaacs, W. B., & Nelson, W. G. (1998) · PubMed · Cited by 282
Self-citationCharache, S., Dover, G., Smith, K., Talbot, C. C., Moyer, M., & Boyer, S. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.15.4842 · Cited by 275
Fatemi, M., Hermann, A., Pradhan, S., & Jeltsch, A. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4709 · Cited by 274
Wu, J., Issa, J. P., Herman, J., Bassett, D. E., Nelkin, B. D., & Baylin, S. B. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.19.8891 · Cited by 253
Ley, T., DeSimone, J., Noguchi, C., Turner, P., Schechter, A., Heller, P., & Nienhuis, A. (1983) · Blood · doi:10.1182/blood.v62.2.370.370 · Cited by 252
Lin, X., Tascilar, M., Lee, W.-H., Vles, W. J., Lee, B. H., Veeraswamy, R., Asgari, K., Freije, D., van Rees, B., Gage, W. R., et al. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63028-3 · Cited by 241
Self-citationRole of DNA 5-Methylcytosine Transferase in Cell Transformation by fos
Bakin, A. V., & Curran, T. (1999) · Science · doi:10.1126/science.283.5400.387 · Cited by 238
Continuous Zebularine Treatment Effectively Sustains Demethylation in Human Bladder Cancer Cells
Cheng, J. C., Weisenberger, D. J., Gonzales, F. A., Liang, G., Xu, G.-L., Hu, Y.-G., Marquez, V. E., & Jones, P. A. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.3.1270-1278.2004 · Cited by 222
Mutagenicity of 5-aza-2′-deoxycytidine is mediated by the mammalian DNA methyltransferase
Jackson-Grusby, L., Laird, P. W., Magge, S. N., Moeller, B. J., & Jaenisch, R. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4681 · Cited by 208
Segura-Pacheco, B. A., Trejo‐Becerril, C., Pérez‐Cárdenas, E., Taja‐Chayeb, L., Mariscal, I., Chavez, A., Acuña, C., Salazar, A. M., Lizano, M., & Dueñas‐González, A. (2003) · PubMed · Cited by 206
Processive Methylation of Hemimethylated CpG Sites by Mouse Dnmt1 DNA Methyltransferase
Vilkaitis, G., Suetake, I., Klimašauskas, S., & Tajima, S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411126200 · Cited by 192
Eads, C. A., Nickel, A. E., & Laird, P. W. (2002) · PubMed · Cited by 181
Lin, X., Asgari, K., PUTZI, M. J., Gage, W. R., Yu, X., Cornblatt, B. S., Kumar, A., Piantadosi, S., DeWeese, T. L., Marzo, A. M. D., et al. (2001) · PubMed · Cited by 180
Self-citationHypermethylation trigger of the glutathione-S-transferase gene (GSTP1) in prostate cancer cells
Song, J. Z., Stirzaker, C., Harrison, J., Melki, J. R., & Clark, S. J. (2002) · Oncogene · doi:10.1038/sj.onc.1205153 · Cited by 177
Increased Protein Stability Causes DNA Methyltransferase 1 Dysregulation in Breast Cancer
Agoston, A. T., Argani, P., Yegnasubramanian, S., Marzo, A. M. D., Ansari-Lari, M. A., Hicks, J. L., Davidson, N. E., & Nelson, W. G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501675200 · Cited by 152
Self-citationProcainamide inhibits DNA methyltransferase in a human T cell line.
Scheinbart, L., Johnson, M. A., Gross, L. A., Edelstein, S., & Richardson, B. C. (1991) · PubMed · Cited by 139
Recombinant Human DNA (Cytosine-5) Methyltransferase
Bacolla, A., Pradhan, S., Roberts, R. J., & Wells, R. D. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.46.33011 · Cited by 131
Mechanism of inhibition of DNA methyltransferases by cytidine analogs in cancer therapy
Gowher, H., & Jeltsch, A. (2004) · Cancer Biology & Therapy · doi:10.4161/cbt.3.11.1308 · Cited by 100
Lin, X. S., & Nelson, W. G. (2003) · PubMed · Cited by 92
Self-citationFlynn, J. F., Glickman, J. F., & Reich, N. O. (1996) · Biochemistry · doi:10.1021/bi9600512 · Cited by 73
Recombinant Human DNA (Cytosine-5) Methyltransferase
Bacolla, A., Pradhan, S., Larson, J. E., Roberts, R. J., & Wells, R. D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100404200 · Cited by 61
Purification of human DNA (cytosine‐5‐)‐methyltransferase
Zucker, K. E., Riggs, A. D., & Smith, S. S. (1985) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240290407 · Cited by 51
DNA Cytosine C5 Methyltransferase Dnmt1: Catalysis-Dependent Release of Allosteric Inhibition
Svedružić, Ž. M., & Reich, N. O. (2005) · Biochemistry · doi:10.1021/bi050295z · Cited by 39
5-Azacytidine increases fetal hemoglobin production in a patient with sickle cell disease.
Gj, D., Charache, S., Boyer, S. H., Cc, T., & Smith, K. D. (1983) · PubMed · Cited by 31
Carine, K., Jacquemin‐Sablon, A., Waltzer, E., Mascarello, J. T., & Scheffler, I. E. (1989) · Somatic Cell and Molecular Genetics · doi:10.1007/bf01534895 · Cited by 29
DNA methylation and globin gene expression in patients treated with 5-azacytidine.
Ley, T. J., Anagnou, N., Noguchi, C. T., Schechter, A. N., DeSimone, J., Heller, P. G., & Nienhuis, A. (1983) · PubMed · Cited by 29
Cited by
Cancer epigenetics reaches mainstream oncology
Rodríguez-Paredes, M., & Esteller, M. (2011) · Nature Medicine · doi:10.1038/nm.2305 · Cited by 1,205
Thangaraju, M., Cresci, G. A., Liu, K., Ananth, S., Gnanaprakasam, J. P., Browning, D. D., Mellinger, J. D., Smith, S. B., Digby, G. J., Lambert, N. A., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4466 · Cited by 789
Cancer chemoprevention by dietary polyphenols: Promising role for epigenetics
Link, A., Balaguer, F., & Goel, A. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.06.036 · Cited by 497
Epigenetic regulation in metabolic diseases: mechanisms and advances in clinical study
Wu, Y.-L., Lin, Z.-J., Li, C.-C., Lin, X., Shan, S.-K., Guo, B., Zheng, M.-H., Li, F., Yuan, L.-Q., & Li, Z.-H. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01333-7 · Cited by 476
Self-citationSerre, D., Lee, B. H., & Ting, A. H. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkp992 · Cited by 404
Self-citation
Metadata
- Authors
- Lee, B. H., Yegnasubramanian, S., Lin, X., & Nelson, W. G.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2005-12
- Volume
- 280
- Issue
- 49
- Pages
- 40749-40756
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2055770867
- Cited by
- 295
- References
- 49
- FWCI
- 3.34
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.